Articles related to BACTERIAL INFECTIONS

Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.

In the realm of otolaryngology, cholesteatoma presents a unique challenge, with a case study revealing a 4.6% recurrence rate and a 5.4% residual disease rate. Continuous monitoring is essential for effective management.

Uncover the hidden health risks at amusement parks. From bacterial exposure to physical injuries, the findings are a wake-up call for public health.

Endophthalmitis is a severe infection that can threaten vision. In a recent case, a patient’s vision did not improve despite treatment with intravitreal antimicrobial agents and an 8-week course of intravenous cefazolin. This underscores the importance of early detection and comprehensive treatment strategies.